| scholarly article | Q13442814 |
| P50 | author | Subhash Verma | Q57951657 |
| Erle S Robertson | Q88590600 | ||
| P2093 | author name string | Sumit Borah | |
| P2860 | cites work | The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa) | Q24310605 |
| hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization | Q24310670 | ||
| Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription | Q24311810 | ||
| Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F | Q24317554 | ||
| Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 | ||
| Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes | Q24538878 | ||
| A functional YY1 binding site is necessary and sufficient to activate Surf-1 promoter activity in response to serum growth factors | Q24545231 | ||
| Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1 | Q24562189 | ||
| Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction | Q24650233 | ||
| Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription | Q24651154 | ||
| The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription | Q28235557 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 | Q28245874 | ||
| KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
| Telomere length regulation | Q28290143 | ||
| Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| A survey of telomerase activity in human cancer | Q29614858 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome | Q30668836 | ||
| Alternative Splicing Variants of IκBβ Establish Differential NF-κB Signal Responsiveness in Human Cells | Q33786480 | ||
| Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene | Q33824419 | ||
| Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33835021 | ||
| Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. | Q33838228 | ||
| The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters | Q33845947 | ||
| Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes | Q33851443 | ||
| DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33853499 | ||
| Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells | Q33854704 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 | ||
| K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation | Q34180268 | ||
| Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter | Q34186131 | ||
| Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism | Q34235866 | ||
| Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. | Q34348453 | ||
| Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1 | Q34350776 | ||
| The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription | Q34362138 | ||
| The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
| Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression | Q34396889 | ||
| Adenovirus E1A: remodelling the host cell, a life or death experience | Q34468761 | ||
| The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
| A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. | Q34531461 | ||
| A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation | Q34920038 | ||
| Erythroid Kruppel-like factor is recruited to the CACCC box in the beta-globin promoter but not to the CACCC box in the gamma-globin promoter: the role of the neighboring promoter elements | Q35074726 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta | Q35104781 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites | Q35555749 | ||
| Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members | Q36486862 | ||
| Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein | Q36647515 | ||
| Chromosome first aid. | Q37430022 | ||
| The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator | Q38306731 | ||
| Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). | Q38316509 | ||
| Functional Interference of Sp1 and NF-κB through the Same DNA Binding Site | Q38339684 | ||
| Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation | Q38345845 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. | Q39700420 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. | Q40682995 | ||
| Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter | Q40730661 | ||
| The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus | Q40746913 | ||
| The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1/CIP1) promoter via interaction with Sp1. | Q40751180 | ||
| The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element | Q40758382 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter | Q40811288 | ||
| Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters | Q40891345 | ||
| Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. | Q40923894 | ||
| In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences | Q40971183 | ||
| Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 smallt to promote cell growth and NF-kappa B activation | Q41089273 | ||
| Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter | Q41267630 | ||
| Transcriptional regulation by the Sp family proteins. | Q41756422 | ||
| A role of the TATA box and the general co-activator hTAF(II)130/135 in promoter-specific trans-activation by simian virus 40 small t antigen. | Q42800510 | ||
| Inhibition of NF-κB-dependent transcription of human immunodeficiency virus 1 promoter by a phosphodiester compound of vitamin C and vitamin E, EPC-K1 | Q45754797 | ||
| Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system | Q45856536 | ||
| The adenoviral E1A induces p21WAF1/CIP1 expression in cancer cells | Q45862463 | ||
| Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus | Q47675996 | ||
| Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene | Q47986055 | ||
| c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. | Q52573384 | ||
| Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer | Q53435668 | ||
| The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus | Q57662902 | ||
| The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
| Structure and function analysis of the human myeloid cell nuclear differentiation antigen promoter: evidence for the role of Sp1 and not of c-Myb or PU.1 in myelomonocytic lineage-specific expression | Q73308150 | ||
| Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues | Q77959517 | ||
| Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells | Q78109137 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10348-10359 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | |
| P478 | volume | 78 |
| Q35973676 | A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. |
| Q27680409 | A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins |
| Q40106826 | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia |
| Q34179693 | A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. |
| Q34648229 | Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. |
| Q26743368 | Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus |
| Q38388893 | At a Crossroads: Human DNA Tumor Viruses and the Host DNA Damage Response |
| Q40343396 | Bovine herpesvirus type 1 (BHV-1) up-regulates telomerase activity in MDBK cells. |
| Q34092739 | Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. |
| Q39675686 | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores |
| Q35943718 | Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q28533244 | Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence |
| Q53039329 | Contribution of Sp1 to Telomerase Expression and Activity in Skin Keratinocytes Cultured With a Feeder Layer |
| Q30418735 | Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma |
| Q40041231 | Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA. |
| Q41891421 | Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus |
| Q39744147 | Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas |
| Q33261811 | EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors |
| Q37057685 | Emmprin and KSHV: new partners in viral cancer pathogenesis. |
| Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
| Q37865141 | Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients |
| Q37060535 | Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program |
| Q34170639 | HIV, EBV and KSHV: Viral cooperation in the pathogenesis of human malignancies |
| Q41957104 | HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). |
| Q39747026 | Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q34423461 | Human viruses and cancer. |
| Q47606258 | Infection of KSHV and Interaction with HIV: The Bad Romance |
| Q38000019 | Infection, mutation, and cancer evolution |
| Q27486093 | Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers |
| Q38107828 | Interplay between DNA tumor viruses and the host DNA damage response. |
| Q26766437 | KSHV Genome Replication and Maintenance |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q40286016 | KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity |
| Q27026000 | KSHV: pathways to tumorigenesis and persistent infection |
| Q28540116 | Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway |
| Q35830666 | Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts |
| Q34186981 | Kaposi's Sarcoma Herpesvirus Upregulates Aurora A Expression to Promote p53 Phosphorylation and Ubiquitylation |
| Q35192868 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Reduces Interleukin-8 Expression in Endothelial Cells and Impairs Neutrophil Chemotaxis by Degrading Nuclear p65 |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q36911800 | Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. |
| Q41846091 | Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation |
| Q39665994 | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency |
| Q40128647 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing |
| Q42049779 | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions |
| Q40607781 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 |
| Q38859450 | Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin |
| Q33744019 | Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency |
| Q24543014 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats |
| Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q36933913 | Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes |
| Q26860203 | Modeling human endothelial cell transformation in vascular neoplasias |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
| Q36252859 | Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency |
| Q40066566 | ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import |
| Q34456086 | Phosphorylation of the chromatin binding domain of KSHV LANA |
| Q35755464 | Post-Translational Modifications of Kaposi’s Sarcoma-Associated Herpesvirus Regulatory Proteins – SUMO and KSHV |
| Q40292424 | Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus |
| Q35774091 | Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen |
| Q33282107 | Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. |
| Q42693319 | RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells |
| Q35080754 | Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA |
| Q37053343 | Regulation of telomerase and telomeres: human tumor viruses take control |
| Q41849965 | Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen |
| Q38144129 | Review of latent and lytic phase biomarkers in Kaposi's sarcoma |
| Q99616354 | Role of DNA methylation and CpG sites in the viral telomerase RNA promoter during Gallid herpesvirus 2 pathogenesis |
| Q37157253 | Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence |
| Q34071388 | Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication |
| Q40605206 | Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. |
| Q35124429 | Structure and function of latency-associated nuclear antigen |
| Q37765230 | Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications |
| Q36497017 | Telomeres and viruses: common themes of genome maintenance. |
| Q35140238 | The Internal Kaposi's Sarcoma-Associated Herpesvirus LANA Regions Exert a Critical Role on Episome Persistence |
| Q36301221 | The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence. |
| Q36099076 | The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
| Q35077558 | The Single RBP-Jκ Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection |
| Q36080884 | The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle |
| Q41860564 | The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains |
| Q37380228 | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency |
| Q84470156 | The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility |
| Q42152999 | The regulation of telomerase in oncogenesis |
| Q36086767 | The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q54216669 | Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development |
| Q26739925 | Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene |
| Q47571734 | Viral Oncology: Molecular Biology and Pathogenesis |
| Q36318145 | Viruses - seeking and destroying the tumor program |
| Q37811898 | Why do viruses cause cancer? Highlights of the first century of human tumour virology |
| Q34717947 | microRNAs in viral oncogenesis |